Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort

Clinical Infectious Diseases(2022)10.1093/cid/ciac086Source: DataRank Database

Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)Impact (FWCI 0.39)OA: bronzeTopics (67)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Robin M. Nance ORCID,Joseph A. Delaney ORCID,Bridget M. Whitney ORCID,Laura Bamford ORCID,Ronnie M. Gravett ORCID

Live enrichment

PubMed:35134850 PMC:PMC9464068 OpenAlex:https://openalex.org/W4210301895

National Institutes of Health

Grant: T32 AI704446

National Institutes of Health

Grant: R24 AI067039

National Institutes of Health

Grant: P30 AI036219

National Institutes of Health

Grant: P30 AI027767

National Institutes of Health

Grant: P30 AI060354

National Institutes of Health

Grant: P30 AI094189

National Institutes of Health

Grant: P30 AI036214

National Institutes of Health

Grant: P30 AI027763

National Institutes of Health

Grant: P30 AI50410

National Institutes of Health

Grant: P30 AI027757

NIAID NIH HHS

Grant: T32 AI007044

NIAID NIH HHS

Grant: P30 AI050410

NIAID NIH HHS

Grant: UM1 AI069452

National Institutes of Health

Grant: 3P30AI027763-12S2

UCSF-GIVI Center for AIDS research

National Institutes of Health

Grant: 5P30AI036214-11

Center for AIDS Research

National Institutes of Health

Grant: 5P30AI036219-20

Ugandan Laboratory Core

National Institutes of Health

Grant: 5P30AI027767-20

UAB Center for AIDS Research

National Institutes of Health

Grant: 3P30AI027757-36S1

University of Washington/Fred Hutch Center for AIDS Research

National Institutes of Health

Grant: 3P30AI094189-13S3

The Johns Hopkins Center for AIDS Research (JHU CFAR)

National Institutes of Health

Grant: 1R24AI067039-01A1

Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS

National Institutes of Health

Grant: 5P30AI050410-05

UNC Center for Aids Research

National Institutes of Health

Grant: 1P30AI060354-01

Harvard Medical School Center for AIDS Research

National Institute of Allergy and Infectious Diseases

FWCI

0.39

Citation Percentile

0.6%

Citation Trend

2023

2024

2025

2026

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/cid/article-pdf/75/4/715/45787092/ciac086.pdf

publisherhttps://academic.oup.com/cid/article-pdf/75/4/715/45787092/ciac086.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac086/43499630/ciac086.pdf

journalhttps://doi.org/10.1093/cid/ciac086

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35134850

Fields of Study

HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV Research and Treatment03 medical and health sciences0302 clinical medicineAcquired Immunodeficiency SyndromeAlanineAnti-HIV AgentsAnti-Retroviral AgentsEmtricitabineHIVHIV InfectionsHeterocyclic Compounds, 3-RingHumansTenofovirUnited States

MeSH Terms

EmtricitabineTenofovirAcquired Immunodeficiency SyndromeAlanineHeterocyclic Compounds, 3-RingHIVHumansUnited StatesHIV InfectionsAnti-HIV AgentsAnti-Retroviral Agents

Keywords

DolutegravirMedicineTenofovir alafenamideHuman immunodeficiency virus (HIV)Antiretroviral therapyGuidelineVirologyCohortFamily medicineViral loadInternal medicineIntegrase inhibitorArt UtilizationArt GuidelinesArt Treatment TrendsAnti-HIV AgentsClinical sciencesHIV Infections3-RingMedical and Health SciencesMicrobiologyHeterocyclic Compounds616EmtricitabineHumansTenofovirAcquired Immunodeficiency SyndromeAlanineBiomedical and Clinical SciencesHIVBiological SciencesUnited StatesInfectious DiseasesGood Health and Well BeingAnti-Retroviral AgentsMedical MicrobiologySexually Transmitted InfectionsHIV/AIDSInfectionHeterocyclic Compounds, 3-Ring

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being